Skip to main content

Human Metabolomics Institute

What's Happening

HMI Stories

Human Metabolomics Institute, Inc. (HMI) is a biomedical enterprise founded by Prof. Wei Jia, a world-leading expert in translational metabolomics research. HMI is dedicated to developing and providing innovative mass spectrometry-based molecular diagnostic solutions for precision medicine and personalized health management. The company, with offices and laboratories located in Shenzhen and Shanghai, has extensive knowledge and expertise in the development of proprietary and integrated technologies of in-vitro diagnostics, targeted metabolic phenotyping, human metabolic database, machine learning and artificial intelligence to advance the early and accurate detection of human disease phenotypes. HMI has a strong executive leadership team specializing in the cutting-edge translational metabolomics research as well as business operation and management. The company is aimed to become the global leader in clinical metabolomics to transform how diseases are predicted, prevented and managed.

HMI

Vision

To become the global leader in clinical metabolomics to transform how diseases are predicted, prevented and managed.

Products and Service

HMI Super Product

HMI offers an array of proprietary IVD kits, including those for scientific research and clinical examination, enabling China to have its own products in this respect, thereby setting up the “golden standards” for the industry with its advanced technologies. In addition, it offers innovative products like AI-enabled auxiliary software and health beverages. HMI also provides outstanding scientific research services, medical laboratory services, health management, and many other services with an advanced management system and high-level quality standards.

Diagnostic Kit

Clinical test kits and chronic disease screening test kits, exclusively developed by HMI, include the one for precise screening of various chronic diseases, offering quantitative analysis targeting hundreds of small-molecule metabolites in a single assessment, a noninvasive rapid test kit for fibrosis and cirrhosis of liver, and risk screening test kits for diabetes, fatty liver, cardiovascular disease, biliary atresia, birth defects, etc.

Medical Examination

Huiyun Medical Laboratory is supported by an experienced technical team, robust scientific research strength, advanced mass spectrometry equipment, and a standardized quality management system. It offers clinical and metabolomics-based testing services through a mass spectrometry platform.

AI Diagnostic Software

HMI has developed AI-enabled auxiliary software options and integrated Internet-based tools, by combining advanced machine learning algorithms with large-scale clinical sample-based data. With these options and tools, HMI is making the early screening of diseases like chronic liver diseases more convenient and efficient on a large-scale basis.

立即寻找
你所需要的

发现新的生物学技术并与我们分享影响。